Hypoglycaemia.
Muneer M.
Adv Exp Med Biol. 2021;1307:43-69. doi: 10.1007/5584_2020_534.
Role of diabetes mellitus on hepatic encephalopathy.
Ampuero J, Ranchal I, del Mar Díaz-Herrero M, del Campo JA, Bautista JD, Romero-Gómez M.
Metab Brain Dis. 2013 Jun;28(2):277-9. doi: 10.1007/s11011-012-9354-2. Epub 2012 Nov 24.
Diabetic Ketoacidosis: Evaluation and Treatment.
Veauthier B, Levy-Grau B.
Am Fam Physician. 2024 Nov;110(5):476-486.
Vitamin A and Diabetes.
Zhang Y, Wang T, Hu X, Chen G.
J Med Food. 2021 Aug;24(8):775-785. doi: 10.1089/jmf.2020.0147. Epub 2020 Nov 24.
Insulin resistance and hepatic steatosis in type 1 diabetes mellitus and their association with diabetic chronic complications.
Popa SG, Simion AM, Soare M, Arcomita D.
Minerva Endocrinol (Torino). 2023 Mar;48(1):27-34. doi: 10.23736/S2724-6507.20.03290-3. Epub 2020 Oct 2.
Pancreatic diabetes mellitus.
Sjoberg RJ, Kidd GS.
Diabetes Care. 1989 Nov-Dec;12(10):715-24. doi: 10.2337/diacare.12.10.715.
Exercise and diabetes.
Chipkin SR, Klugh SA, Chasan-Taber L.
Cardiol Clin. 2001 Aug;19(3):489-505. doi: 10.1016/s0733-8651(05)70231-9.
Dorzagliatin: First Approval.
Syed YY.
Drugs. 2022 Dec;82(18):1745-1750. doi: 10.1007/s40265-022-01813-0.
Cystic fibrosis-related diabetes.
Mackie AD, Thornton SJ, Edenborough FP.
Diabet Med. 2003 Jun;20(6):425-36. doi: 10.1046/j.1464-5491.2003.00924.x.
Renal Tubular Damage Marker, Urinary N-acetyl-beta-D-Glucosaminidase, as a Predictive Marker of Hepatic Fibrosis in Type 2 Diabetes Mellitus.
Kim HK, Lee M, Lee YH, Kang ES, Cha BS, Lee BW.
Diabetes Metab J. 2022 Jan;46(1):104-116. doi: 10.4093/dmj.2020.0273. Epub 2021 Jul 13.
